BioAtla (BCAB) Shares Outstanding (Entity) (2020 - 2026)
BioAtla (BCAB) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.16 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 147.69 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 200.18 Mn |
| 10 | BioAtla | 5.74 Mn | 5.74 Mn | - | 1.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.66 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 966,911.00 |
| Jun 30, 2024 | 966,523.00 |
| Mar 31, 2024 | 962,126.00 |
| Dec 31, 2023 | 961,552.00 |
| Sep 30, 2023 | 958,148.00 |
| Jun 30, 2023 | 956,066.00 |
| Mar 31, 2023 | 952,746.00 |
| Dec 31, 2022 | 926,723.00 |
| Sep 30, 2022 | 727,306.00 |
| Jun 30, 2022 | 748,407.00 |
| Mar 31, 2022 | 717,826.00 |
| Dec 31, 2021 | 715,985.00 |
| Sep 30, 2021 | 703,809.00 |
| Jun 30, 2021 | 646,306.00 |